Sleep Monitor First To Pre-Diagnose Sleep Apnea

Heralded as a medical-market first, Shanghai Megahealth, with the help of the Novelda company, has developed a non-contact sleep monitoring system that measures the amount and quality of sleep plus Apnea–Hypopnea Index (AHI), the medical parameter used to indicate the severity of sleep apnea. The innovative system has received China FDA approval.


According to the company, currently available sleep monitors are not accurate enough to correctly analyze sleep patterns. Diagnosing severe sleeping disorders, like sleep apnea, involves the use of bulky polysomnography equipment that is uncomfortable and may affect a patient’s sleep quality. The use of a non-contact method to measure sleep apnea was not yet a figure on the horizon. Shanghai Megahealth’s solution is the first non-contact sleep monitoring system capable of measuring sleep apnea.

Free Newsletter

Like this article? Subscribe to FierceSensors!

The sensors industry is constantly changing as innovation runs the market’s trends. FierceSensors subscribers rely on our suite of newsletters as their must-read source for the latest news, developments and analysis impacting their world. Register today to get sensors news and updates delivered right to your inbox.


In the US, sleep apnea syndrome affects about 4% of men and 2% of women. The complications of sleep apnea include high blood pressure, heart disease, diabetes, daytime sleepiness, and difficulty concentrating and remembering. As AHI is a medical parameter, therefore only medical grade equipment with verifiable accuracy and safety is permissible to measure this index.


 According to Wang Jian Jun, COO of Shanghai Megahealth, “Finding the right technology partner was critical to our development. We found a few sensor solutions available that can do non-contact vital signs monitoring but they all have severe limitations. Novelda however, with its unique UWB impulse radar sensor technology, has effectively overcome all these limitations. Combined with Megahealth’s own medical-grade hardware system and patented analysis algorithm, the M+ Sleep Monitoring system accurately measures respiration rate, respiration amplitude, whole body movement, sleep time, sleep cycles and AHI.”


Bjørn Åge Brandal, Novelda’s VP of sales, elaborates “The fact that Megahealth’s M+ Sleep system built on Novelda’s XeThru sensors has received medical approval is testimony not only to the accuracy of our sensor technology but also to the fact that our radar sensors are 100% safe.”


The M+ sleep monitoring solution is available now for purchase directly from Shanghai Megahealth. However, the company’s website is in Chinese with no options for English or other languages. Interested parties may want to try calling Wang Jian Jun at Shanghai Megahealth via phone at +86-21-60760258 or making contact via email: [email protected]


For more details about Novelda sensors, visit the company’s website. ~MD


Suggested Articles

Two economic studies on expanding tech jobs to dozens of heartland places in the U.S. provoke a discussion on good work, good life.

Integration of Symantec business expected to help with security software sales

Analysts predict 5G shipments to explode in number in 2020